HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor activity of four macrocyclic ellagitannins from Cuphea hyssopifolia.

Abstract
We evaluated the antitumor activities of four macrocyclic hydrolyzable tannin dimers, cuphiin D1, cuphiin D2, oenothein B and woodfordin C isolated from Cuphea hyssopifolia (Lythraceae). All significantly inhibited the growth of the human carcinoma cell lines KB, HeLa, DU-145, Hep 3B, and the leukemia cell line HL-60, and showed less cytotoxicity than adriamycin against a normal cell line (WISH). All four compounds inhibited the viability of S-180 tumor cells in an in vitro assay and an in vivo S-180 tumor-bearing ICR mice model. Oenothein B demonstrated the greatest cytotoxicity (IC50 = 11.4 microg/ml) against S-180 tumor cells in culture, while cuphiin D1 resulted in the greatest increase in survival on S-180 tumor-bearing mice (%ILS = 84.1%). Our findings suggest that the antitumor effects of these compounds are not only related to their cytotoxicity on carcinoma cell lines, but also depended on a host-mediated mechanism; they may therefore have potential for antitumor applications.
AuthorsC C Wang, L G Chen, L L Yang
JournalCancer letters (Cancer Lett) Vol. 140 Issue 1-2 Pg. 195-200 (Jun 01 1999) ISSN: 0304-3835 [Print] Ireland
PMID10403559 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Hydrolyzable Tannins
  • Tannins
  • cuphiin D(1)
  • cuphiin D(2)
  • oenothein B
  • woodfordin C
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology, therapeutic use)
  • Body Weight (drug effects)
  • Cell Division (drug effects)
  • Drug Evaluation, Preclinical
  • Humans
  • Hydrolyzable Tannins
  • Male
  • Mice
  • Mice, Inbred ICR
  • Neoplasm Transplantation
  • Neoplasms, Experimental (drug therapy, mortality, pathology)
  • Survival Rate
  • Tannins (pharmacology, therapeutic use)
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: